Titlebook: Ventricular-Assist Devices and Kidney Disease; Clinical Perspective Chaitanya Desai,William G. Cotts,Michael R. Rudnic Book 2018 Springer I

constellation

加剧

CLASH

Understanding Cardiovascular Hemodynamics,ar hemodynamics. This chapter explores the assessment of cardiovascular hemodynamics and how this assessment can be used to guide management. Special attention is given to the assessment and management of advanced heart failure and left ventricular assist devices.

乳汁

Cardiorenal Syndromes, organ have a direct impact on the other organs, and can lead to worsened patient outcomes. We know that mortality is increased in patients with heart failure (HF) who have a reduced glomerular filtration rate (GFR). We also know that patients with chronic kidney disease (CKD) have an increased risk

沙发

nocturia

纬线

History of Durable Mechanical Circulatory Assist Devices, demand. Patients with end-stage heart failure can now safely undergo durable left ventricular assist device (LVAD) implantation. Furthermore, LVAD therapy has now expanded beyond patients who are not transplant candidates. About 50% of patients who undergo VAD implantation in the current era are im

Inflamed

UNT

Effects of Ventricular Assist Device Therapies on Renal Function, therapy. LVAD implantation restores cardiac output, improving hemodynamics and reversing neurohormonal dysregulation. The effect of LVAD support on renal pathophysiology is complex and not well understood. Renal dysfunction (RD) occurs commonly in HF patients. Many develop cardiorenal syndrome (CRS

integral

Management of Hypertension after Ventricular Assist Device Implant,Hypertension is a well-established risk factor for renal disease and stroke in the absence of a left ventricular assist device. There is increasing evidence that hypertension also contributes to various adverse outcomes including stroke, aortic insufficiency, and thromboembolic events in left ventri